Indium111CapromabPendetideChecker

Indium-111 Capromab Pendetide

radiopharmaceuticals QC URS & FS input.csv output.json radiochemical purity radionuclidic purity In-111
Open selection

Utility description: Indium-111 Capromab Pendetide

Indium-111 Capromab Pendetide Quality Checker — Indium-111 Capromab Pendetide (ProstaScint®)

ℹ️  Utility checks critical parameters of the monoclonal antibody-based radiopharmaceutical:
    • Radiochemical purity (≥90%)
    • Free Indium-111 impurity (≤5%)
    • Colloidal Indium-111 impurity (≤5%)
    • Specific activity (100–400 MBq/mg)
    • pH, endotoxins, sterility, heavy metals

⚠️  CRITICAL: Free Indium-111 accumulates in bone marrow and liver!
    Colloidal Indium-111 is taken up by the reticuloendothelial system (liver/spleen)!
    This creates background noise, interfering with prostate metastasis imaging.

Usage:
  Indium111CapromabPendetideChecker.exe                            → demo mode (console output)
  Indium111CapromabPendetideChecker.exe input.csv output.json      → evaluate your data

Input format:
BatchNumber,RadiochemicalPurityPercent,FreeIndium111Percent,ColloidalIndium111Percent,SpecificActivityMBqPerMg,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProteinConcentrationMgPerMl

Example (sterility: 0=sterile, 1=contaminated):
  IN111-CP-2026-001,96.5,1.5,2.0,185.0,6.8,120.0,0,4,1.0

— WHY IS THIS NEEDED?
Indium-111 Capromab Pendetide (ProstaScint®) is a radioimmunoconjugate for prostate cancer scintigraphy.
• Indium-111 (T½=2.8 days) emits gamma rays (171 and 245 keV), ideal for gamma cameras.
• Capromab pendetide is a monoclonal antibody (7E11-C5.3) binding to prostate-specific membrane antigen (PSMA).
• Used to detect recurrence after prostatectomy or radiation therapy.

⚠️  CRITICAL:
• Radiochemical purity ≥90% — ensures most activity is bound to the antibody and reaches the target.
• Free Indium-111 ≤5% — unbound indium accumulates in bone marrow, mimicking or hiding metastases.
• Colloidal Indium-111 ≤5% — hydrolyzed indium is taken up by liver and spleen, creating high abdominal background.
• pH 6.0–7.5 — critical for antibody stability and injection compatibility.
• Endotoxins ≤350 EU/vial — safety standard for parenterals.
• Sterility — MANDATORY!

Key features:
• Separate control of free and colloidal indium (two different degradation/impurity mechanisms).
• Specific activity control to ensure sufficient signal while maintaining immunological activity.
• Aggregation check (indirectly via RCP).

Critical parameters:
• Radiochemical purity: ≥90.0%
• Free Indium-111: ≤5.0%
• Colloidal Indium-111: ≤5.0%
• Specific activity: 100–400 MBq/mg
• pH: 6.0–7.5
• Endotoxins: ≤350 EU/vial
• Sterility: no microbial growth
• Heavy metals: ≤10 ppm

💡 Usage tips:
1. RCP is determined by TLC (Thin Layer Chromatography) using two solvent systems.
2. System 1 (e.g., 0.9% NaCl): determines free In-111 (Rf=1.0) and conjugate/colloid (Rf=0.0).
3. System 2 (e.g., 10% ammonium acetate:methanol 1:1): determines colloid (Rf=0.0) and conjugate/free (Rf=1.0).
4. Calculation: % Conjugate = 100% - (% Free + % Colloid).
5. The product must be used within 24 hours after labeling.

⚠️ Note: Unlike small molecules, antibodies are sensitive to labeling conditions. Excess metal or incorrect pH leads to colloid formation. Insufficient incubation time leaves free indium. Both factors critically reduce the diagnostic value of the study.

input.csv

BatchNumber,RadiochemicalPurityPercent,FreeIndium111Percent,ColloidalIndium111Percent,SpecificActivityMBqPerMg,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProteinConcentrationMgPerMl
IN111-CP-2026-001,96.5,1.5,2.0,185.0,6.8,120.0,0,4,1.0
IN111-CP-2026-002,88.0,8.0,4.0,190.0,6.5,110.0,0,5,1.0

URS & FS — User Requirements and Functional Specification

This document describes the controlled interface and behaviour of Indium111CapromabPendetideChecker for Indium-111 Capromab Pendetide.

Domain limits and critical parameters

Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.
  • ℹ️ Utility checks critical parameters of the monoclonal antibody-based radiopharmaceutical:
  • • Radiochemical purity (≥90%)
  • • Free Indium-111 impurity (≤5%)
  • • Colloidal Indium-111 impurity (≤5%)
  • • pH, endotoxins, sterility, heavy metals
  • ⚠️ CRITICAL: Free Indium-111 accumulates in bone marrow and liver!
  • BatchNumber,RadiochemicalPurityPercent,FreeIndium111Percent,ColloidalIndium111Percent,SpecificActivityMBqPerMg,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProteinConcentrationMgPerMl
  • Example (sterility: 0=sterile, 1=contaminated):
  • ⚠️ CRITICAL:
  • • Radiochemical purity ≥90% — ensures most activity is bound to the antibody and reaches the target.
  • • Free Indium-111 ≤5% — unbound indium accumulates in bone marrow, mimicking or hiding metastases.
  • • Colloidal Indium-111 ≤5% — hydrolyzed indium is taken up by liver and spleen, creating high abdominal background.
  • • pH 6.0–7.5 — critical for antibody stability and injection compatibility.
  • • Endotoxins ≤350 EU/vial — safety standard for parenterals.

URS — User Requirements Specification

IDRequirementCriticalityAcceptance criterion
URS-001The utility shall accept an input.csv file with the exact headers defined in the data contract.HighThe file is processed without manual header editing.
URS-002The utility shall perform deterministic QC evaluation for Indium-111 Capromab Pendetide using input values, approved limits and domain rules.HighEach input row receives a PASS / WARNING / FAIL status.
URS-003The utility shall validate mandatory fields, data types, numeric ranges, units and pharmaceutical/radiochemical plausibility.HighSchema and conversion errors are explicitly reported.
URS-004The utility shall identify critical deviations related to radionuclidic purity, radiochemical purity, free radionuclide, impurities, pH, endotoxins and sterility when such fields are present.HighA critical deviation causes FAIL or a separate critical finding.
URS-005The utility shall generate output.json with machine-readable results, source values, warnings and failures.HighJSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-006The utility shall not use machine learning to decide conformance.MediumThe result is based on explicit rules, thresholds and input values.
URS-007The utility shall preserve traceability between batch number, input values, applied rules and final status.HighThe output contains the batch identifier and the list of checked parameters.
URS-008The documentation shall support IQ/OQ preparation and inspection discussion with FDA/EMA/Roszdravnadzor or local regulators.MediumURS & FS, input.csv/output.json contract and test scenarios are supplied with the utility.

input.csv contract

#FieldTypeSamplePurpose
1BatchNumberstringIN111-CP-2026-001Batch or lot identifier used for traceability.
2RadiochemicalPurityPercentstring96.5Radiochemical purity; confirms the labelled chemical form and binding quality.
3FreeIndium111Percentdecimal1.5Free radionuclide / unbound species; important for non-target uptake and toxicity.
4ColloidalIndium111Percentstring2.0Controlled input parameter used by the deterministic QC rules.
5SpecificActivityMBqPerMgdecimal185.0Radioactivity value used for release, decay or dose-related assessment.
6pHdecimal6.8Solution pH; relevant for stability, compatibility and administration.
7EndotoxinsEUdecimal120.0Bacterial endotoxins; critical for parenteral administration.
8SterilityTestflag / boolean0Sterility result; critical release parameter.
9HeavyMetalsPPMdecimal4Elemental impurity / metal residue parameter.
10ProteinConcentrationMgPerMldecimal1.0Controlled input parameter used by the deterministic QC rules.
BatchNumber,RadiochemicalPurityPercent,FreeIndium111Percent,ColloidalIndium111Percent,SpecificActivityMBqPerMg,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProteinConcentrationMgPerMl
IN111-CP-2026-001,96.5,1.5,2.0,185.0,6.8,120.0,0,4,1.0
IN111-CP-2026-002,88.0,8.0,4.0,190.0,6.5,110.0,0,5,1.0

FS — Functional Specification

IDFunctionImplementation
FS-001CSV importRead input.csv in UTF-8/CSV-compatible format and validate the header and expected columns.
FS-002Schema validationCheck mandatory fields and column count; report unknown or missing key fields.
FS-003Type conversionConvert numeric, flag and text values; invalid formats are recorded as row-level errors.
FS-004Domain rule engineApply domain rules for Indium-111 Capromab Pendetide, including critical limits from the utility description and approved specification.
FS-005Status aggregationProduce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-006JSON exportWrite output.json with detailed checks, source values, warnings, failures and critical findings.
FS-007Audit supportKeep the result structure suitable for review, deviation investigation, calculation reproduction and IQ/OQ preparation.
FS-008Integration contractSupport the production scenario: LIMS/ELN/MES creates input.csv, the utility returns output.json, the portal displays description and documentation.

Example output.json

{
  "utilityId": "indium111-capromab-pendetide-checker",
  "api": "Indium-111 Capromab Pendetide",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "IN111-CP-2026-001",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadiochemicalPurityPercent",
      "value": "96.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "FreeIndium111Percent",
      "value": "1.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "ColloidalIndium111Percent",
      "value": "2.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "SpecificActivityMBqPerMg",
      "value": "185.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "pH",
      "value": "6.8",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "EndotoxinsEU",
      "value": "120.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "SterilityTest",
      "value": "0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": []
}

OQ/PQ test scenarios

IDScenarioExpected result
OQ-001Valid sample rowPASS or acceptable WARNING according to the rules.
OQ-002Mandatory column missingSchema error or FAIL.
OQ-003Non-numeric value in numeric fieldType-conversion error.
OQ-004Critical parameter outside limitFAIL and critical finding.
PQ-001User real batch/lotReviewed result with input.csv and output.json retained.

QA/QC and change control

  • Do not rename columns without updating the validator and test set.
  • Retain input.csv, output.json, executable version and checksum.
  • Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
  • Critical radiopharmaceutical limits must be verified against the approved specification and local SOPs.

Included in packages

Andrology QC Suite

QC package for andrology: androgens, erectile-dysfunction medicines, BPH/prostate products, fertility and related hormonal checks.

Open

PetRad3: expanded PET/SPECT and radiopharmaceutical QC package

A curated suite for PET/SPECT radiopharmaceuticals, generator and cyclotron radionuclides, labelled compounds, radiochemical purity, breakthrough, sterility and endotoxin control.

Open

Radiology QC Suite

QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.

Open

RPH isotope family: labelled cells and blood

In-111 and Cr-51 for labelled cells, blood volume, RBC/WBC and survival workflows.

Open

RPH organ/system: bone and musculoskeletal

Bone scintigraphy, MDP/PYP, marrow, bone-pain palliation, skeletal metastases and radiosynovectomy.

Open

RPH organ/system: hepatobiliary and GI

HIDA, mebrofenin, gallbladder, gastric emptying, GI transit, bleeding and liver/spleen imaging.

Open

RPH organ/system: oncology and theranostics

Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.

Open

RPH use case: generators, isotope purity and starting radionuclides

Control of generator eluate, breakthrough, radionuclidic purity, isotope mix, carrier/free radionuclides and starting radionuclides before labeling.

Open

RPH workflow: generators and isotope purity

Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.

Open

RPH workflow: imaging QC and quantitative interpretation

Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.

Open

RPH workflow: instruments, devices and radiation safety

PET/gamma-camera state, calibration, detector QC, energy window, TOF, shielding and radiation safety.

Open

RPH workflow: product release QC

Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.

Open

RPH workflow: stability, storage, decay and waste

Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.

Open

RPH workflow: synthesis, labelling and kit reconstitution

Radiolabelling, synthesis, chelation, reducing agent, pH/stoichiometry and kit preparation.

Open

RPH: combined radiopharmaceutical QC package

RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.

Open

Urology QC Suite

QC package for urology: BPH, urolithiasis, overactive bladder, urinary-tract infection medicines and supporting antimicrobial QC checks.

Open